Non Hodgkin Lymphoma Clinical Trial
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Summary
To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.
View Eligibility Criteria
Eligibility Criteria
Inclusion Criteria:
Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant
Exclusion Criteria:
Participation in any other treatment research protocol
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There is 1 Location for this study
See Locations Near You
Wake Forest Baptist Health
Winston-Salem North Carolina, 27157, United States More Info
Winston-Salem North Carolina, 27157, United States More Info
David Hurd, MD
Principal Investigator
Principal Investigator
How clear is this clinincal trial information?